TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Vein graft occlusion at 2 years
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Improvement of functional level (NDI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Range of motion (cervical spine)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Transient dyspnea index (TDI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Duration of physical activity with 1.0–1.5 METs
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Clinical Global Impressions‐Severity of Illness scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Brief Assessment of Cognition in Schizophrenia score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: GDD improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Staff attendance/completion of education topics
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Management of hypoglycaemia
Endpoint domain: Adverse events/effects
Primary endpoint: overall efficacy of Fludora® Fusion WG-SB
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PPAR-γ mRNA expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: HGS (Hand Grip Strength)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median time to first treatment failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median time to first institutionalization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient's outcome perception
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: MDS-UPDRS motor scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: proportion of participants without follicle rupture more than 5 days post-LNG dosing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Postoperative NKA levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: WBS score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BWAT score reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: degree of upper airway obstruction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Vascular injuries
Endpoint domain: Adverse events/effects
Primary endpoint: Bowel injuries
Endpoint domain: Adverse events/effects
Primary endpoint: 2-month non-progression rate
Endpoint domain: Mortality/survival
Primary endpoint: Change in PMHQ score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Decrease in caregiver burden (ZBI-7)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Preeclampsia rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: severity of ichthyosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mucocutaneous infections
Endpoint domain: Adverse events/effects
Primary endpoint: sweep gas flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cognitive impairment at 3-month follow-up
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Risk of postoperative pulmonary complications (PPCs)
Endpoint domain: Adverse events/effects
Primary endpoint: Corneal Densitometry
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Corneal Aberrations (HO-RMS and Total RMS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: personal accomplishment (burnout)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: frequency of negative emotions
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Reaction Time (RT) during single-task assessments
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reaction Time (RT) during dual-task assessments
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total coping
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Reduction in NPI or BPRS total score at week 2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Individual symptom score reductions at week 2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: muscle hypertrophy of the anterior and middle deltoid
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: complete resolution
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: seizure recurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: calcification on follow-up imaging
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Correct surveillance interval assignment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Negative predictive value (NPV) for rectosigmoid adenomas
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: completion of any needed service
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: completion of Pap test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: completion of smoking cessation counseling
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: symmetry in swing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: stance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: single support percentage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: toe angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: freedom from atrial tachyarrhythmias off antiarrhythmic drugs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Achieving ≥85% RDI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ACTIVLIM scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: ASD symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: social/social-communication skills
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cognitive rating scale scores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Progressive motile sperm count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: DEd
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Average duration of NIV treatment time
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: nNO test values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Compliance rate for commencing the partograph
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Postthrombotic syndrome severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of MSCs
Endpoint domain: Adverse events/effects
Primary endpoint: Recovery and discharge without complications
Endpoint domain: Mortality/survival
Primary endpoint: Use of antipsychotics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean difference in allied health service events
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Average volume of contrast medium needed to reach AES
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anterior epidural spread (AES) percentage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neural spread percentage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Halos reported by patients
Endpoint domain: Adverse events/effects
Primary endpoint: First-attempt procedure time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite of cardiovascular death, myocardial infarction, and hospitalization for unstable angina, heart failure, or cardiac arrest
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Risk for motor impairment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of rickets
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Height-for-age z score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: minimum thickness of the lower wall of the maxillary sinus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: minimum density of the maxillary sinus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DIAAS (Digestible Indispensable Amino Acid Score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Psychiatric disorders
Endpoint domain: Adverse events/effects
Primary endpoint: Average hemoglobin at weeks 18-24
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maintenance rate of hemoglobin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Progression from pre-hypertension to hypertension
Endpoint domain: Mortality/survival
Primary endpoint: Reduction in BP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: MYMOP-2 scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Lipid concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Caloric content
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Health-related physical fitness improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Inaccuracy of risk perception
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Changes in CMRS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in WC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Objective comprehension score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DUI behaviors and arrests
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of skin rash and pruritus
Endpoint domain: Adverse events/effects
Primary endpoint: incidence of anaemia at 30 days after TKA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: haemoglobin concentration at 30 days after TKA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: serum ferritin concentrations at 30 days after TKA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: lower limb power output
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: worst daily pain experienced
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Patient-Reported Improvement in Migraine Burden Symptoms (PI-MBS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Adherence to BTCP assessment practices
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in pain interference
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: survival rate of the first skin graft
Endpoint domain: Mortality/survival
Primary endpoint: number of days from treatment to skin grafting
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: competency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increased coagulation factor VIII activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Increased von Willebrand factor level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Increased phosphorylated fibrinopeptide A level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Disabling strokes
Endpoint domain: Mortality/survival
Primary endpoint: New permanent pacemaker implantation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: healthy baby rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Frequency of urgency episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Daily urinary frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Improved psychological QoL
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Improved pubertal QoL
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Improved total QoL
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: successful placement rates for the first attempt
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Composite nephropathy outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Cases of SARS-CoV-2 infection detected
Endpoint domain: Mortality/survival
Primary endpoint: Reduction in intrahepatic lipid (IHL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Reduction in serum free fatty acids (FFA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Increase in serum interleukin-6 (IL-6)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Plasma interleukin‐6 concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Plasma interleukin‐8 concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Plasma interleukin‐10 concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: extension deficits of less than 5°
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: duration of surgeries
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: CPTSD-RI score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CPQ11-14 score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: microbial diversity and composition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Triglycerides changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Creatine kinase level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: NQ‐E score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: RBANS score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Serum urate target achievement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gout flares
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of acute grade ? 3 neutropenia
Endpoint domain: Adverse events/effects
Primary endpoint: Perceived quality of life (physical component)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: VAS desire to eat increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CNS disease progression
Endpoint domain: Mortality/survival
Primary endpoint: Mild anxiety management
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: distribution across mRS categories
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of respiratory drainage (RD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Complications or ineffectual drains
Endpoint domain: Adverse events/effects
Primary endpoint: Immunogenicity profiles (Anti-drug Antibody)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of nausea and/or vomiting
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: quality-of-life outcomes
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Curative resections
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma PAI‐1 concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Cost of hospital admissions
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Cost of emergency department presentation
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: total score of cognitive assessment
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Knowledge improvement in ergonomics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mobility assessments
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in microcirculatory flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Meantime to 20% increase in microcirculatory blood volume and blood flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: UPDRS-III score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity of acute kidney injury (AKI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Duration of acute kidney injury (AKI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: ED50 and ED90 of intrathecal ropivacaine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: excess deaths
Endpoint domain: Mortality/survival
Primary endpoint: 3D MOT performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: fewer cannabis-related problems
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: fewer quit attempts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Need for IMV
Endpoint domain: Mortality/survival
Primary endpoint: neural mechanosensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: PPT in the dermatome of the median nerve
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: PPT at carpal tunnel
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Proportion of sedation measurements in the light sedation range
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative midazolam dosage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: probability of vitrectomy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: total executive functioning
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: fatigue self-management behaviours
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Average plasma glucose (0-24 h)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under curve of glucose infused (AUC-GIR[0-24 h])
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tinetti POMA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Genotype distribution of TMPRSS6 rs855791
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Trunk flexor and extensor strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: endline folate concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: prevalence of folate deficiency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Intentions to engage in future preventative health actions
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Reported taking preventative health action after reading a health blog
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Mean postoperative hemoglobin loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Negative posttreatment stool antigen results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Variability of RV
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Detection rate of advanced neoplasia (AN)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Colorectal cancer (CRC) diagnosis rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: experienced discrimination
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing